|
|
||||||||
Gastrointestinal Research Laboratory, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi 371, Japan
The effect of motilin on insulin release has not
been studied in the interdigestive state. Adult mongrel dogs were
chronically implanted with force transducers in the stomach and
duodenum to monitor contractile activity, and the plasma motilin and
insulin concentrations were measured by a specific radioimmunoassay and enzyme immunoassay, respectively. The concentration of insulin in
plasma was found to fluctuate in close association with that of motilin
and phase III of the interdigestive migrating contractions in the
stomach. This spontaneous release of insulin was mimicked by
intravenous infusion of motilin at a dose of 0.3 µg · kg
1 · h
1.
Exogenous motilin (0.01-0.3 µg/kg) dose dependently stimulated insulin release, which was abolished by atropine, hexamethonium, ondansetron, and truncal vagotomy. Phentolamine significantly enhanced,
whereas propranolol inhibited, motilin-induced insulin release. In a
perifusion system using islet cells from the canine pancreas, motilin
did not affect insulin release. In conclusion, motilin stimulates
insulin release through vagal cholinergic, muscarinic receptors on
pancreatic
-cells, and the effect appears to be modulated by
adrenergic nerves.
conscious dog;
-cell; parasympathetic nervous
system
This article has been cited by other articles:
![]() |
N. Ueno, A. Inui, A. Asakawa, F. Takao, A. Ichibangase, Y. Komatsu, and M. Kasuga Erythromycin Administration Before Sleep is Effective in Decreasing Fasting Hyperglycemia in Type 2 Diabetic Patients Diabetes Care, March 1, 2001; 24(3): 607 - 607. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |